Autophagy Modulation by Lanthionine Ketimine Ethyl Ester Improves Long-Term Outcome after Central Fluid Percussion Injury in the Mouse

Journal of Neurotrauma

Volumn 33, Issue 16, 2016, Pages 1501-1513

  Hensley, Kenneth ^a   Poteshkina, Aleksandra ^c   Johnson, Ming F ^c   Eslami, Pirooz ^c   Gabbita, S Prasad ^b   Hristov, Alexandar M ^a   Venkova Hristova, Kalina M ^a   Harris White, Marni E ^c,d  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b P2D Inc   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

autophagy; behavior; diffuse axon injury; pathology

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; LANTHIONINE KETIMINE ETHYL ESTER; NEUROFILAMENT H PROTEIN; NEUROFILAMENT PROTEIN; NEUROPROTECTIVE AGENT; PROTEIN C JUN; TAU PROTEIN; UNCLASSIFIED DRUG; LANTHIONINE KETIMINE; SULFUR AMINO ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BLOOD LEVEL; BRAIN INJURY; BRAIN LEVEL; CENTRAL FLUID PERCUSSION INJURY; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LEARNING DISORDER; MALE; MEMORY DISORDER; MOLECULAR DYNAMICS; MOUSE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANIMAL; C57BL MOUSE; DIFFUSE AXONAL INJURY; DISEASE MODEL; DRUG EFFECTS;

AMINO ACIDS, SULFUR; ANIMALS; AUTOPHAGY; DIFFUSE AXONAL INJURY; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED C57BL;

EID: 84983666729     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2015.4196     Document Type: Article

References (89)

1. Rand, C.W., and Courville, C.B. (1946). Histologic changes in the brain in cases of fatal injury to the head. Arch. Neurol. Psychiatry 31, 527-555.
2. Strich, S.J., and Oxon, D.M. (1961). Shearing of nerve fibers as a cause of brain damage due to head injury. Lancet 2, 443-448.
3. Nevin, N.C. (1967). Neuropathological changes in the white matter following head injury. J. Neuropathol. Exp. Neurol. 26, 77-84.
4. Peerless, S.J., and Rewcastle, N.B. (1967). Shear injuries of the brain. Can. Med. Assoc. J. 96, 577-582.
5. Oppenheimer, D.R. (1968). Microscopic lesions in the brain following head injury. J. Neurol Neurosurg. Psychiatry 31, 299-306.
6. Tomlinson, B.E. (1970). Brain-stem lesions after head injury. J. Clin. Pathol. Suppl (R Coll Pathol) 4, 154-165.
7. Adams, H., Mitchell, D.E., Graham, D.I., and Doyle, D. (1977). Diffuse brain damage of immediate impact type. Its relationship to 'primary brain-stem damage' in head injury. Brain 100, 489-502.
8. Povlishock, J.T., Becker, D.P., Cheng, C.L., and Vaughan, G.W. (1983). Axonal change in minor head injury. J. Neuropathol. Exp. Neurol. 42, 225-242.
9. Gennarelli, T.A. (1996). The spectrum of traumatic axonal injury. Neuropathol. Appl. Neurobiol. 22, 509-513.
10. Maxwell, W.L., and Graham, D.I. (1997). Loss of axonal microtubules and neurofilaments after stretch-injury to guinea pig optic nerve fibers. J. Neurotrauma 14, 603-614.
11. Buki, A., Siman, R., Trojanowski, J.Q., and Povlishock, J.T. (1999). The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury. J. Neuropathol. Exp. Neurol. 58, 365-375.
12. Okonkwo, D.O., Pettus, E.H., Moroi, J., and Povlishock, J.T. (1998). Alteration of the neurofilament sidearm and its relation to neurofilament compaction occurring with traumatic axonal injury. Brain Res. 784, 1-6.
13. Pettus, E.H., and Povlishock, J.T. (1996). Characterization of a distinct set of intra-axonal ultrastructural changes associated with traumatically induced alteration in axolemmal permeability. Brain Res. 722, 1-11.
14. Saatman, K.E., Bozyczko-Coyne, D., Marcy, V., Siman, R., and McIntosh, T.K. (1996). Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J. Neuropathol. Exp. Neurol. 55, 850-860.
15. Stone, J.R., Singleton, R.H., and Povlishock, J.T. (2001). Intra-axonal neurofilament compaction does not evoke local axonal swelling in all traumatically injured axons. Exp. Neurol. 172, 320-331.
16. Adams, J.H., Doyle, D., Ford, I., Gennarelli, T.A., Graham, D.I., and McLellan, D.R. (1989). Diffuse axonal injury in head injury: definition, diagnosis and grading. Histopathology 15, 49-59.
17. Smith, D.H., Meaney, D.F., and Shull, W.H. (2003). Diffuse axonal injury in head trauma. J. Head Trauma Rehabil. 18, 307-316.
18. Blumbergs, P.C., Scott, G., Manavis, J., Wainwright, H., Simpson, D.A., and McLean, A.J. (1994). Staining of amyloid precursor protein to study axonal damage in mild head injury. Lancet 344, 1055-1056.
19. Johnson, V.E., Stewart, W., and Smith, D.H. (2013). Axonal pathology in traumatic brain injury. Exp. Neurol. 246, 35-43.
20. McMillan, T.M., Teasdale, G.M., and Stewart, E. (2012). Disability in young people and adults after head injury: 12-14 year follow-up of a prospective cohort. J. Neurol. Neurosurg. Psychiatry 83, 1086-1091.
21. Mayeux, R., Ottman, R., Maestre, G., Ngai, C., Tang, M.X., Ginsberg, H., Chun, M., Tycko, B., and Shelanski, M. (1995). Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology 45, 555-557.
22. Ricard, D., Rogemond, V., Charrier, E., Aguera, M., Bagnard, D., Belin, M.F., Thomasset, N., and Honnorat, J. (2001). Isolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/CRMP2 in Sema3a- sensitive oligodendrocytes. J. Neurosci. 21, 7203-7214.
23. Uchida, Y., Ohshima, T., Sasaki, Y., Suzuki, H., Yanai, S., Yamashita, N., Nakamura, F., Takei, K., Ihara, Y., Mikoshiba, K., Kolattukudy, P., Honnorat, J., and Goshima, Y. (2005). Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes Cells 10, 165-179.
24. Fukata, Y., Itoh, T.J., Kimura, T., Menager, C., Nishimura, T., Shiromizu, T., Watanabe, H., Inagaki, N., Iwamatsu, A., Hotani, H., and Kaibuchi, K. (2002). CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat. Cell Biol. 4, 583-591.
25. Arimura, N., Kimura, T., Nakamuta, S., Taya, S., Funahashi, Y., Hattori, A., Shimada, A., Menager, C., Kawabata, S., Fujii, K., Iwamatsu, A., Segal, R.A., Fukuda, M., and Kaibuchi, K. (2009). Anterograde transport of TrkB in axons is mediated by direct interaction with Slp1 and Rab27. Dev. Cell 16, 675-686.
26. Kawano, Y., Yoshimura, T., Tsuboi, D., Kawabata, S., Kaneko- Kawano, T., Shirataki, H., Takenawa, T., and Kaibuchi, K. (2005). CRMP-2 is involved in kinesin-1-dependent transport of the Sra-1/ WAVE1 complex and axon formation. Mol. Cell Biol 25, 9920-9935.
27. Mimura, F., Yamagishi, S., Arimura, N., Fujitani, M., Kubo, T., Kaibuchi, K., and Yamashita, T. (2006). Myelin-associated glycoprotein inhibits microtubule assembly by a Rho-kinase-dependent mechanism. J. Biol. Chem. 281, 15970-15979.
28. Gogel, S., Lange, S., Leung, K.Y., Greene, N.D., and Ferretti, P. (2010). Post-translational regulation of Crmp in developing and regenerating chick spinal cord. Dev. Neurobiol. 70, 456-471.
29. Touma, E., Kato, S., Fukui, K., and Koike, T. (2007). Calpainmediated cleavage of collapsin response mediator protein(CRMP)-2 during neurite degeneration in mice. Eur. J. Neurosci. 26, 3368-3381.
30. Fu, M.M., Nirschl, J.J., and Holzbaur, E.L. (2014). LC3 binding to the scaffolding protein JIP1 regulates processive dynein-driven transport of autophagosomes. Dev. Cell 29, 577-590.
31. Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., and Mizushima, N. (2006). Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885-889.
32. Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., and Tanaka, K. (2006). Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880-884.
33. Lee, S., Sato, Y., and Nixon, R.A. (2011). Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy. J. Neurosci. 31, 7817-7830.
34. Ashrafi, G., and Schwarz, T.L. (2013). The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 20, 31-42.
35. Dagda, R.K., Cherra, S.J., 3rd, Kulich, S.M., Tandon, A., Park, D., and Chu, C.T. (2009). Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J. Biol. Chem. 284, 13843-13855.
36. Lynch-Day, M.A., Mao, K., Wang, K., Zhao, M., and Klionsky, D.J. (2012). The role of autophagy in Parkinson's disease. Cold Spring Harb. Perspect. Med. 2, a009357.
37. Narendra, D., Tanaka, A., Suen, D.F., and Youle, R.J. (2008). Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183, 795-803.
38. Martinez-Vicente, M., Talloczy, Z., Wong, E., Tang, G., Koga, H., Kaushik, S., de Vries, R., Arias, E., Harris, S., Sulzer, D., and Cuervo, A.M. (2010). Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat. Neurosci. 13, 567-576.
39. Wong, Y.C., and Holzbaur, E.L. (2014). The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation. J. Neurosci. 34, 1293-1305.
40. Ravikumar, B., Acevedo-Arozena, A., Imarisio, S., Berger, Z., Vacher, C., O'Kane, C.J., Brown, S.D., and Rubinsztein, D.C. (2005). Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat. Genet. 37, 771-776.
41. Rubino, E., Rainero, I., Chio, A., Rogaeva, E., Galimberti, D., Fenoglio, P., Grinberg, Y., Isaia, G., Calvo, A., Gentile, S., Bruni, A.C., St George- Hyslop, P.H., Scarpini, E., Gallone, S., Pinessi, L., and YODEM Study Group. (2012). SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology 79, 1556-1562.
42. Hollenbeck, P.J. (1993). Products of endocytosis and autophagy are retrieved from axons by regulated retrograde organelle transport. J. Cell Biol. 121, 305-315.
43. Maday, S., Wallace, K.E., and Holzbaur, E.L. (2012). Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons. J. Cell Biol. 196, 407-417.
44. Au, A.K., Bayir, H., Kochanek, P.M., and Clark, R.S. (2010). Evaluation of autophagy using mouse models of brain injury. Biochim. Biophys. Acta 1802, 918-923.
45. Luo, C.L., Li, B.X., Li, Q.Q., Chen, X.P., Sun, Y.X., Bao, H.J., Dai, D.K., Shen, Y.W., Xu, H.F., Ni, H., Wan, L., Qin, Z.H., Tao, L.Y., and Zhao, Z.Q. (2011). Autophagy is involved in traumatic brain injuryinduced cell death and contributes to functional outcome deficits in mice. Neuroscience 184, 54-63.
46. Smith, C.M., Chen, Y., Sullivan, M.L., Kochanek, P.M., and Clark, R.S. (2011). Autophagy in acute brain injury: feast, famine, or folly? Neurobiol. Dis. 43, 52-59.
47. Harris-White, M.E., Ferbas, K.G., Johnson, M.F., Eslami, P., Poteshkina, A., Venkova, K., Christov, A., and Hensley, K. (2015). A cell-penetrating ester of the neural metabolite lanthionine ketimine stimulates autophagy through the mTORC1 pathway: evidence for a mechanism of action with pharmacological implications for neurodegenerative pathologies. Neurobiol. Dis.84, 60-68.
48. Hensley, K., Gabbita, S.P., Venkova, K., Hristov, A., Johnson, M.F., Eslami, P., and Harris-White, M.E. (2013). A derivative of the brain metabolite lanthionine ketimine improves cognition and diminishes pathology in the 3 x Tg-AD mouse model of Alzheimer disease. J. Neuropathol. Exp. Neurol. 72, 955-969.
49. Hensley, K., Christov, A., Kamat, S., Zhang, X.C., Jackson, K.W., Snow, S., and Post, J. (2010). Proteomic identification of binding partners for the brain metabolite lanthionine ketimine (LK) and documentation of LK effects onmicroglia and motoneuron cell cultures. J. Neurosci. 30, 2979-2988.
50. Hensley, K., Venkova, K., Christov, A., Gunning, W., and Park, J. (2011). Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications. Mol. Neurobiol. 43, 180-191.
51. Hubbard, C., Benda, E., Hardin, T., Baxter, T., St John, E., O'Brien, S., Hensley, K., and Holgado, A.M. (2013). Lanthionine ketimine ethyl ester partially rescues neurodevelopmental defects in unc-33 (DPYSL2/CRMP2) mutants. J. Neurosci. Res. 91, 1183-1190.
52. Greer, J.E., McGinn, M.J., and Povlishock, J.T. (2011). Diffuse traumatic axonal injury in the mouse induces atrophy, c-Jun activation, and axonal outgrowth in the axotomized neuronal population. J. Neurosci. 31, 5089-5105.
53. Dixon, C.E., Lyeth, B.G., Povlishock, J.T., Findling, R.L., Hamm, R.J., Marmarou, A., Young, H.F., and Hayes, R.L. (1987).A fluid percussion model of experimental brain injury in the rat. J. Neurosurg. 67, 110-119.
54. Hensley, K., Venkova, K., and Christov, A. (2010). Emerging biological importance of central nervous system lanthionines.Molecules 15, 5581-5594.
55. Guyenet, S.J., Furrer, S.A., Damian, V.M., Baughan, T.D., La Spada, A.R., and Garden, G.A. (2010). A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. J. Vis. Exp.
56. Arque, G., Fotaki, V., Fernandez, D., Martinez de Lagran, M., Arbones, M.L., and Dierssen, M. (2008). Impaired spatial learning strategies and novel object recognition in mice haploinsufficient for the dual specificity tyrosine-regulated kinase-1A (Dyrk1A). PLoS One 3, e2575.
57. Brandeis, R., Brandys, Y., and Yehuda, S. (1989). The use of the Morris Water Maze in the study of memory and learning. Int. J. Neurosci. 48, 29-69.
58. Sharma, S., Rakoczy, S. and Brown-Borg, H. (2010). Assessment of spatial memory in mice. Life Sci 87, 521-536.
59. Gabbita, S.P., Scheff, S.W., Menard, R.M., Roberts, K., Fugaccia, I., and Zemlan, F.P. (2005). Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury. J. Neurotrauma 22, 83-94.
60. Ham, J., Eilers, A., Whitfield, J., Neame, S.J., and Shah, B. (2000). c- Jun and the transcriptional control of neuronal apoptosis. Biochem. Pharmacol. 60, 1015-1021.
61. Xu, P., Das, M., Reilly, J., and Davis, R.J. (2011). JNK regulates FoxO-dependent autophagy in neurons. Genes Dev. 25, 310-322.
62. Gadea, A., Schinelli, S., and Gallo, V. (2008). Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway. J. Neurosci. 28, 2394-2408.
63. Farrell, J.A., Zhang, J., Jones, M.V., Deboy, C.A., Hoffman, P.N., Landman, B.A., Smith, S.A., Reich, D.S., Calabresi, P.A., and van Zijl, P.C. (2010). q-space and conventional diffusion imaging of axon and myelin damage in the rat spinal cord after axotomy. Magn. Reson. Med, 63, 1323-1335.
64. Shaw, G.J., Jauch, E.C., and Zemlan, F.P. (2002). Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury. Ann. Emerg. Med. 39, 254-257.
65. Zemlan, F.P., Jauch, E.C., Mulchahey, J.J., Gabbita, S.P., Rosenberg, W.S., Speciale, S.G., and Zuccarello, M. (2002). C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res. 947, 131-139.
66. Taghian, K., Lee, J.Y., and Petratos, S. (2012). Phosphorylation and cleavage of the family of collapsin response mediator proteins may play a central role in neurodegeneration after CNS trauma. J. Neurotrauma 29, 1728-1735.
67. Zhang, Z., Ottens, A.K., Sadasivan, S., Kobeissy, F.H., Fang, T., Hayes, R.L., and Wang, K.K. (2007). Calpain-mediated collapsin response mediator protein-1, -2, and -4 proteolysis after neurotoxic and traumatic brain injury. J. Neurotrauma 24, 460-472.
68. Ravikumar, B., Sarkar, S., Davies, J.E., Futter, M., Garcia-Arencibia, M., Green-Thompson, Z.W., Jimenez-Sanchez, M., Korolchuk, V.I., Lichtenberg, M., Luo, S., Massey, D.C., Menzies, F.M., Moreau, K., Narayanan, U., Renna, M., Siddiqi, F.H., Underwood, B.R., Winslow, A.R., and Rubinsztein, D.C. (2010). Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev. 90, 1383-1435.
69. Wirth, M., Joachim, J., and Tooze, S.A. (2013). Autophagosome formation-the role of ULK1 and Beclin1-PI3KC3 complexes in setting the stage. Semin. Cancer Biol. 23, 301-309.
70. Gallagher, L.E., and Chan, E.Y. (2013). Early signalling events of autophagy. Essays Biochem. 55, 1-15.
71. Chiang, G.G., and Abraham, R.T. (2005). Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J. Biol. Chem. 280, 25485-25490.
72. Viscomi, M.T., D'Amelio, M., Cavallucci, V., Latini, L., Bisicchia, E., Nazio, F., Fanelli, F., Maccarrone, M., Moreno, S., Cecconi, F., and Molinari, M. (2012). Stimulation of autophagy by rapamycin protects neurons from remote degeneration after acute focal brain damage. Autophagy 8, 222-235.
73. Mizushima, N., and Yoshimori, T. (2007). How to interpret LC3 immunoblotting. Autophagy 3, 542-545.
74. Ekmark-Lewen, S., Flygt, J., Kiwanuka, O., Meyerson, B.J., Lewen, A., Hillered, L., and Marklund, N. (2013). Traumatic axonal injury in the mouse is accompanied by a dynamic inflammatory response, astroglial reactivity and complex behavioral changes. J. Neuroinflammation 10, 44.
75. Hensley, K., and Denton, T.T. (2015). Alternative functions of the brain transsulfuration pathway represent an underappreciated aspect of brain redox biochemistry with significant potential for therapeutic engagement. Free Radic. Biol. Med. 78, 123-134.
76. Cavallini, D., Ricci, G., and Federici, G. (1983). The ketamine derivatives of thialysine, lanthionine, cystathionine, cystine: preparation and properties. Prog. Clin. Biol. Res. 125, 355-363.
77. Nada, S.E., Tulsulkar, J., Raghavan, A., Hensley, K., and Shah, Z.A. (2012). A derivative of the CRMP2 binding compound lanthionine ketimine provides neuroprotection in a mouse model of cerebral ischemia. Neurochem. Int. 61, 1357-1363.
78. Li, W., Herman, R.K., and Shaw, J.E. (1992). Analysis of the Caenorhabditis elegans axonal guidance and outgrowth gene unc-33. Genetics 132, 675-689.
79. Takemoto, T., Sasaki, Y., Hamajima, N., Goshima, Y., Nonaka, M., and Kimura, H. (2000). Cloning and characterization of the Caenorhabditis elegans CeCRMP/DHP-1 and -2; common ancestors of CRMP and dihydropyrimidinase? Gene 261, 259-267.
80. Tsuboi, D., Hikita, T., Qadota, H., Amano, M., and Kaibuchi, K. (2005). Regulatory machinery of UNC-33 Ce-CRMP localization in neurites during neuronal development in Caenorhabditis elegans. J. Neurochem. 95, 1629-1641.
81. Button, R.W., Luo, S., and Rubinsztein, D.C. (2015). Autophagic activity in neuronal cell death. Neurosci. Bull. 31, 382-394.
82. Diskin, T., Tal-Or, P., Erlich, S., Mizrachy, L., Alexandrovich, A., Shohami, E., and Pinkas-Kramarski, R. (2005). Closed head injury induces upregulation of Beclin 1 at the cortical site of injury. J. Neurotrauma 22, 750-762.
83. Sarkar, C., Zhao, Z., Aungst, S., Sabirzhanov, B., Faden, A.I., and Lipinski, M.M. (2014). Impaired autophagy flux is associated with neuronal cell death after traumatic brain injury. Autophagy 10, 2208-2222.
84. Guo, D., Zeng, L., Brody, D.L., and Wong, M. (2013). Rapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injury. PLoS One 8, e64078.
85. Erlich, S., Alexandrovich, A., Shohami, E., and Pinkas-Kramarski, R. (2007). Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol. Dis. 26, 86-93.
86. Fogel, A.L., Hill, S., and Teng, J.M. (2015). Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology. J. Am. Acad. Dermatol. 72, 879-889.
87. Mortimer, J.A., van Duijn, C.M., Chandra, V., Fratiglioni, L., Graves, A.B., Heyman, A., Jorm, A.F., Kokmen, E., Kondo, K., Rocca, W.A., et al. (1991). Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20, Suppl 2, S28-S35.
88. Green, R.E., Colella, B., Maller, J.J., Bayley, M., Glazer, J., and Mikulis, D.J. (2014). Scale and pattern of atrophy in the chronic stages of moderate-severe TBI. Front. Hum. Neurosci. 8, 67.
89. Yang, L., Clarke, M.J., Carlson, B.L., Mladek, A.C., Schroeder, M.A., Decker, P., Wu, W., Kitange, G.J., Grogan, P.T., Goble, J.M., Uhm, J., Galanis, E., Giannini, C., Lane, H.A., James, C.D., and Sarkaria, J.N. (2008). PTEN loss does not predict for response to RAD001 (Everolimus) in a glioblastoma orthotopic xenograft test panel. Clin. Cancer Res. 14, 3993-4001.